ATE414172T1 - Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden - Google Patents

Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden

Info

Publication number
ATE414172T1
ATE414172T1 AT00952514T AT00952514T ATE414172T1 AT E414172 T1 ATE414172 T1 AT E414172T1 AT 00952514 T AT00952514 T AT 00952514T AT 00952514 T AT00952514 T AT 00952514T AT E414172 T1 ATE414172 T1 AT E414172T1
Authority
AT
Austria
Prior art keywords
antigens
infection
expressed
microbial
during
Prior art date
Application number
AT00952514T
Other languages
English (en)
Inventor
Ann Progulske-Fox
Martin Handfield
L Brady
Jeffrey Hillman
Original Assignee
Oragenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oragenics Inc filed Critical Oragenics Inc
Application granted granted Critical
Publication of ATE414172T1 publication Critical patent/ATE414172T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00952514T 1999-08-06 2000-08-04 Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden ATE414172T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14755199P 1999-08-06 1999-08-06

Publications (1)

Publication Number Publication Date
ATE414172T1 true ATE414172T1 (de) 2008-11-15

Family

ID=22522023

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00952514T ATE414172T1 (de) 1999-08-06 2000-08-04 Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden

Country Status (13)

Country Link
US (1) US8034571B1 (de)
EP (1) EP1238102B1 (de)
AT (1) ATE414172T1 (de)
AU (1) AU778821B2 (de)
CA (1) CA2374156C (de)
DE (2) DE60040804D1 (de)
DK (1) DK1238102T3 (de)
ES (1) ES2184659T1 (de)
HK (1) HK1050029B (de)
IL (2) IL146544A0 (de)
MX (1) MXPA01012787A (de)
NZ (2) NZ515553A (de)
WO (1) WO2001011081A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720139B1 (en) 1999-01-27 2004-04-13 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation in Escherichia coli
ATE414172T1 (de) 1999-08-06 2008-11-15 Oragenics Inc Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden
US7033748B2 (en) * 1999-08-06 2006-04-25 Ivigene Corporation Identification of microbial polynucleotides expressed during infection of a host
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
WO2004045499A2 (en) * 2002-11-20 2004-06-03 University Of Florida Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
US7052860B2 (en) 2001-11-28 2006-05-30 University Of Florida Research Foundation Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
JP2006519586A (ja) * 2002-11-20 2006-08-31 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド 歯周疾患の診断、治療、およびモニタリングのためのアクチノバチルス・アクチノミセテムコミタンス抗原の同定
WO2005019249A2 (en) 2003-08-15 2005-03-03 University Of Florida Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789157A (en) * 1990-06-11 1998-08-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue selex
US20040247611A1 (en) 1994-05-23 2004-12-09 Montana State University Identification of pathogen-ligand interactions
US6013443A (en) * 1995-05-03 2000-01-11 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue SELEX
JP4150082B2 (ja) 1996-08-27 2008-09-17 カイロン コーポレイション 独特の髄膜炎菌性ｂエピトープを規定するモノクローナル抗体およびワクチン組成物の調製におけるそれらの使用
WO1998030910A1 (en) * 1997-01-09 1998-07-16 Whitehead Institute For Biomedical Research Subtractive antibody screening (sas) and uses therefor
CA2286335C (en) 1997-04-15 2007-02-27 Barnes-Jewish Hospital Methods of obtaining antigens specific for fungi, antibodies for such antigens, and diagnosis of disease using such antigens and/or antibodies
US6040144A (en) 1997-07-25 2000-03-21 Mount Sinai School Of Medicine Procedure for preparing gene expression libraries enriched for secretory protein genes
WO1999015897A1 (en) * 1997-09-19 1999-04-01 Chiron Corporation Subtractive protein screening for gene identification
WO1999032633A1 (en) 1997-12-19 1999-07-01 Heska Corporation Toxoplasma gondii proteins, corresponding nucleic acid molecules, and uses thereof
ATE414172T1 (de) 1999-08-06 2008-11-15 Oragenics Inc Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden

Also Published As

Publication number Publication date
IL146544A0 (en) 2002-07-25
NZ515553A (en) 2005-01-28
EP1238102B1 (de) 2008-11-12
AU6519700A (en) 2001-03-05
NZ531589A (en) 2005-08-26
MXPA01012787A (es) 2005-08-26
HK1050029A1 (en) 2003-06-06
DK1238102T3 (da) 2009-02-09
CA2374156A1 (en) 2001-02-15
US8034571B1 (en) 2011-10-11
ES2184659T1 (es) 2003-04-16
DE1238102T1 (de) 2003-05-28
WO2001011081A2 (en) 2001-02-15
EP1238102A2 (de) 2002-09-11
CA2374156C (en) 2008-01-29
IL146544A (en) 2008-11-26
WO2001011081A3 (en) 2002-07-11
AU778821B2 (en) 2004-12-23
DE60040804D1 (de) 2008-12-24
HK1050029B (zh) 2009-03-27

Similar Documents

Publication Publication Date Title
ATE414172T1 (de) Mikrobielle polynukleotide, die während der infekton eines wirts exprimiert werden
CA2201587A1 (en) Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
MY125202A (en) Vaccine
EA200100565A1 (ru) Новые стрептококковые антигены
NZ330887A (en) Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
WO2005062972A3 (en) Treatment of cancer with novel anti-il 13 monoclonal antibodies
JP2008285675A (ja) 修飾したメニンゴコッカスのポリサッカライドを結合したワクチン
WO2000076540A3 (en) Streptococcus pneumoniae proteins and vaccines
HUP0102304A1 (hu) B Csoportba tartozó Streptococcus antigének
PT83255A (en) Process for the preparation of polypeptides and characteristic antibodies of papillomavirus and diagnostic method thereto
WO2002004496A3 (en) Fimh adhesin proteins and methods of use
WO1998045328A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
CA2217522A1 (en) Isolated frpb nucleic acid molecule and vaccine
EA200100700A1 (ru) Гены и белки и их применение
AU548623B2 (en) Production of antibodies
FR2781158B1 (fr) Nouvelles proteines modifiees immunogenes non immunosuppressives, leur procede de preparation et leurs applications
JP6319927B2 (ja) Ｐｏｒｐｈｙｒｏｍｏｎａｓ ｇｕｌａｅの線毛タイプ
IL148741A0 (en) Vaccine
MXPA01010186A (es) Composiciones y metodos para el tratamiento y diagnostico de cancer de mama.
WO2004015063A3 (en) Amplification and overexpression of oncogenes
Moskophidis et al. Molecular characterization of glycoprotein antigens on surface of Treponema pallidum: comparison with nonpathogenic Treponema phagedenis biotype Reiter
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
JPH08208704A (ja) 新規な糖タンパク質複合体、その製造方法、並びに抗腫瘍剤、免疫調節剤及び増殖因子阻害剤
Ostapenko et al. Primary chemotherapy in conservative treatment of stage II breast cancer patients

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties